LRIG2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.221600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.419800E-01
Normal-vs-Stage2
6.333400E-01
Normal-vs-Stage3
4.242000E-01
Normal-vs-Stage4
7.196800E-01
Stage1-vs-Stage2
9.751400E-01
Stage1-vs-Stage3
8.817900E-02
Stage1-vs-Stage4
1.501670E-02
Stage2-vs-Stage3
1.599780E-01
Stage2-vs-Stage4
5.421900E-03
Stage3-vs-Stage4
2.760500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.198800E-01
Normal-vs-AfricanAmerican
6.739800E-01
Normal-vs-Asian
5.316400E-01
Caucasian-vs-AfricanAmerican
3.578200E-01
Caucasian-vs-Asian
3.515400E-01
AfricanAmerican-vs-Asian
2.453000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.129400E-01
Normal-vs-Female
6.353200E-01
Male-vs-Female
6.800800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.102000E-01
Normal-vs-Age(41-60Yrs)
7.126600E-01
Normal-vs-Age(61-80Yrs)
5.917400E-01
Normal-vs-Age(81-100Yrs)
5.234400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.218000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.408400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.847600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.999600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.328500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.672000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.580200E-01
Normal-vs-Daily Drinker
5.474400E-01
Normal-vs-Weekly Drinker
5.207400E-01
Normal-vs-Occasional Drinker
6.780800E-01
Normal-vs-Social Drinker
6.630200E-01
Non Drinker-vs-Daily Drinker
8.850000E-01
Non Drinker-vs-Weekly Drinker
6.529000E-01
Non Drinker-vs-Occasional Drinker
1.887610E-01
Non Drinker-vs-Social Drinker
2.989400E-01
Daily Drinker-vs-Weekly Drinker
7.765400E-01
Daily Drinker-vs-Occasional Drinker
1.976850E-01
Daily Drinker-vs-Social Drinker
3.022600E-01
Weekly Drinker-vs-Occasional Drinker
1.410840E-01
Weekly Drinker-vs-Social Drinker
2.285200E-01
Occasional Drinker-vs-Social Drinker
8.905600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.224200E-01
Normal-vs-Grade 2
1.766310E-02
Normal-vs-Grade 3
1.603690E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.946000E-02
Grade 1-vs-Grade 3
8.737900E-02
Grade 1-vs-Grade 4
2.224200E-01
Grade 2-vs-Grade 3
7.790800E-01
Grade 2-vs-Grade 4
1.766310E-02
Grade 3-vs-Grade 4
1.603690E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.572000E-01
Normal-vs-NonDiabetic
5.874600E-01
Diabetic-vs-NonDiabetic
5.696600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.498200E-01
Normal-vs-NoPancreatitis
5.782400E-01
Pancreatitis-vs-NoPancreatitis
4.633200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.245600E-01
Normal-vs-N1
6.317800E-01
N0-vs-N1
8.880600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.050400E-01
Normal-vs-TP53-NonMutant
5.622000E-01
TP53-Mutant-vs-TP53-NonMutant
7.284000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
